Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

• Hoofdauteurs: Iñigo Les (Auteur), Inés Pérez-Francisco (Auteur), María Cabero (Auteur), Cristina Sánchez (Auteur), María Hidalgo (Auteur), Lucía Teijeira (Auteur), Virginia Arrazubi (Auteur), Severina Domínguez (Auteur), Pilar Anaut (Auteur), Saioa Eguiluz (Auteur), Iñaki Elejalde (Auteur), Alberto Herrera (Auteur), Mireia Martínez (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Introduction: Immune checkpoint inhibitor (ICI) therapy is markedly improving the prognosis of patients with several types of cancer. On the other hand, the growth in the use of these drugs in oncology is associated with an increase in multiple immune-related adverse events (irAEs), whose optimal pr...